← All trials
NCT05251870
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 17, 2021
- Primary completion
- Aug 31, 2024
- Completion date
- Aug 31, 2025
- First posted
- Feb 23, 2022
- Last posted
- Feb 23, 2022
- Enrollment
- 18
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Utrecht UniversityLead sponsor
- Dutch Arthritis AssociationCollaborator
- Health HollandCollaborator
- Radboud UniversityCollaborator
- Utrecht UniversityOverall official - principal investigator
- Utrecht UniversityReponsible party - principal investigator
- Utrecht UniversityStudy director
- Utrecht UniversityCollaborator
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
- Utrecht UniversityOfficial
- Utrecht UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.